Thrombosis and Haemostasis,
Год журнала:
2023,
Номер
124(02), С. 135 - 148
Опубликована: Июнь 27, 2023
Polypharmacy
may
affect
outcomes
in
patients
with
atrial
fibrillation
(AF)
using
non-vitamin
K
antagonist
oral
anticoagulants
(NOACs)
or
vitamin
antagonists
(VKAs)
due
to
interactions
reduced
adherence,
but
comparative
data
are
lacking.
Therefore,
the
impact
of
polypharmacy
on
AF-related
and
benefit-risk
profiles
NOACs
were
investigated.
Expert Opinion on Drug Safety,
Год журнала:
2018,
Номер
17(12), С. 1185 - 1196
Опубликована: Дек. 2, 2018
Polypharmacy,
the
use
of
multiple
medications
by
one
individual,
is
increasingly
common
among
older
adults.
Caring
for
growing
number
people
with
complex
drug
regimens
and
multimorbidity
presents
an
important
challenge
in
coming
years.This
article
reviews
international
trends
prevalence
polypharmacy,
summarizes
results
from
previous
on
polypharmacy
negative
health
outcomes,
updates
a
review
clinical
consequences
focusing
studies
published
after
2013.
This
narrative
review,
which
based
literature
search
MEDLINE
EMBASE
January
1990
to
June
2018,
was
undertaken
identify
relevant
articles.
Search
terms
included
variations
medications.The
increasing
worldwide.
More
than
half
population
exposed
some
settings.
Polypharmacy
associated
broad
range
consequences.
However,
methods
assess
dangers
should
be
refined.
In
our
opinion,
issue
'confounding
multimorbidity'
has
been
underestimated
better
accounted
future
studies.
Moreover,
researchers
develop
more
clinically
definitions
including
measures
inappropriate
or
problematic
polypharmacy.
British Journal of Clinical Pharmacology,
Год журнала:
2018,
Номер
84(7), С. 1432 - 1444
Опубликована: Март 25, 2018
Frailty
is
a
complex
geriatric
syndrome
resulting
in
decreased
physiological
reserves.
and
polypharmacy
are
common
older
adults
the
focus
of
extensive
studies,
although
little
known
about
impact
they
may
have
on
each
other.
This
first
systematic
review
analysing
available
evidence
relationship
between
frailty
adults.Systematic
quantitative
studies.
A
comprehensive
literature
search
for
publications
English
or
Spanish
was
performed
MEDLINE,
CINAHL,
Cochrane
Database
PsycINFO
September
2017
without
applying
restrictions
date
publication.
Studies
reporting
any
were
considered.A
total
25
included,
all
them
observational
Evaluation
Fried's
criteria
most
approach,
followed
by
Edmonton
Frail
Scale
FRAIL
scale.
Sixteen
18
cross-sectional
analyses
five
seven
longitudinal
demonstrated
significant
association
an
increased
number
medications
frailty.
The
causal
unclear
appears
to
be
bidirectional.
Our
analysis
published
data
suggests
that
could
major
contributor
development
frailty.A
reduction
cautious
strategy
prevent
manage
Further
research
needed
confirm
possible
benefits
reducing
development,
reversion
delay
Studies
of
the
intestinal
microbiome
and
AD
have
demonstrated
associations
with
composition
at
genus
level
among
matched
cohorts.
We
move
this
body
literature
forward
by
more
deeply
investigating
via
metagenomics
comparing
patients
against
those
without
dementia
other
types.
also
exploit
machine
learning
approaches
that
combine
both
metagenomic
clinical
data.
Finally,
our
functional
studies
using
stool
samples
from
elders
demonstrate
how
c
can
affect
health
dysregulation
P-glycoprotein
pathway.
contributes
directly
to
inflammatory
disorders
intestine.
Since
has
been
long
thought
be
linked
chronic
bacterial
infections
as
a
possible
etiology,
findings
therefore
fill
gap
in
knowledge
field
research
identifying
nexus
between
microbiome,
loss
homeostasis,
inflammation
may
underlie
neurodegenerative
disorder.
Journal of the American Medical Directors Association,
Год журнала:
2020,
Номер
21(2), С. 181 - 187
Опубликована: Янв. 8, 2020
ObjectivePolypharmacy
is
widespread
among
older
people,
but
the
adverse
outcomes
associated
with
it
are
unclear.
We
aim
to
synthesize
current
evidence
on
health,
social,
medicines
management,
and
health
care
utilization
of
polypharmacy
in
people.DesignA
systematic
review,
reviews
meta-analyses
observational
studies,
was
conducted.
Eleven
bibliographic
databases
were
searched
from
1990
February
2018.
Quality
assessed
using
AMSTAR
(A
Measurement
Tool
Assess
Systematic
Reviews).Setting
participantsOlder
people
any
setting,
residential
or
country.ResultsTwenty-six
reporting
230
unique
studies
included.
Almost
all
operationalized
as
medication
count,
few
examined
classes
disease
states
within
this.
Evidence
for
an
association
between
many
outcomes,
including
drug
events
disability,
conflicting.
The
most
consistent
found
hospitalization
inappropriate
prescribing.
No
research
had
explored
very
old
(aged
≥85
years),
potential
social
consequences
use,
such
loneliness
isolation.Conclusions
implicationsThe
literature
examining
complex,
extensive,
Until
a
more
clinically
relevant
manner,
will
not
be
fully
understood.
Future
should
work
toward
this
approach
face
rising
multimorbidity
population
aging.
Therapeutic Advances in Drug Safety,
Год журнала:
2020,
Номер
11
Опубликована: Янв. 1, 2020
A
high
rate
of
polypharmacy
is,
in
part,
a
consequence
the
increasing
proportion
multimorbidity
ageing
population
worldwide.
Our
understanding
potential
harm
taking
multiple
medications
an
older,
multi-morbid
population,
who
are
likely
to
be
on
regime,
is
limited.
This
narrative
literature
review
that
aims
appraise
and
summarise
recent
studies
published
about
polypharmacy.
We
searched
MEDLINE
using
search
terms
(and
its
variations,
e.g.
prescriptions,
inappropriate
drug
use,
etc.)
titles.
Systematic
reviews
original
English
between
2003
2018
were
included.
In
this
review,
we
provide
current
definitions
identify
determinants
prevalence
reported
different
studies.
Finally,
some
findings
regarding
association
health
outcomes
older
adults,
with
focus
frailty,
hospitalisation
mortality.
Polypharmacy
was
most
often
defined
number
being
taken
by
individual
at
any
given
time.
showed
varied
10%
as
around
90%
populations.
Chronic
conditions,
demographics,
socioeconomics
self-assessed
factors
independent
predictors
associated
various
adverse
after
adjusting
for
conditions.
Optimising
care
valid,
reliable
measures,
relevant
all
patients,
will
improve
adult
population.
European Geriatric Medicine,
Год журнала:
2021,
Номер
12(3), С. 443 - 452
Опубликована: Март 10, 2021
Abstract
Background
The
number
of
older
adults
has
been
constantly
growing
around
the
globe.
Consequently,
multimorbidity
and
related
polypharmacy
have
become
an
increasing
problem.
In
absence
accepted
agreement
on
definition
polypharmacy,
data
its
prevalence
in
various
studies
are
not
easily
comparable.
Besides,
evidence
potential
adverse
clinical
outcomes
to
is
limited
though
linked
numerous
outcomes.
This
narrative
review
aims
find
summarize
recent
publications
definitions,
epidemiology
consequences
polypharmacy.
Methods
MEDLINE
database
was
used
identify
definition,
using
their
respective
common
terms
variations.
Systematic
reviews
original
published
between
2015
2020
were
included.
Results
One
hundred
forty-three
definitions
associated
found.
Most
them
numerical
definitions.
Its
ranges
from
4%
among
community-dwelling
people
over
96.5%
hospitalized
patients.
addition,
with
Conclusion
term
imprecise,
yet
subject
ongoing
debate.
clinically
oriented
found
this
such
as
appropriate
or
necessary
more
useful
relevant.
Regardless
highly
prevalent
adults,
particularly
nursing
home
residents
Approaches
increase
appropriateness
can
improve
adults.
OECD health working papers,
Год журнала:
2020,
Номер
unknown
Опубликована: Май 30, 2020
While
health
care
quality
has
been
improving
on
average
in
OECD
members
countries,
patient
safety
remains
a
central
priority
for
policy
makers
and
leaders.
A
growing
research
body
found
that
PSC
is
associated
with
numerous
positive
outcomes,
including
improved
experience,
organisational
productivity
staff
satisfaction.
Tools
to
measure
have
proliferated
recent
decades
are
now
wide-spread
use.
This
report
includes
findings
from
countries
the
state
of
art
measurement
practices
related
PSC.
Overall,
prevalent
across
though
application,
purpose,
tools
vary.
International
learning
benchmarking
significant
potential
better
understanding
improvement
quality.
Abstract
Introduction
Polypharmacy
is
commonly
associated
with
adverse
health
outcomes.
There
are
currently
no
meta-analyses
of
the
prevalence
polypharmacy
or
factors
polypharmacy.
We
aimed
to
estimate
pooled
and
in
a
systematic
review
meta-analysis.
Methods
MEDLINE,
EMBASE,
Cochrane
databases
were
searched
for
studies
restrictions
on
date.
included
observational
that
reported
among
individuals
over
age
19.
Two
reviewers
extracted
study
characteristics
including
definitions,
design,
setting,
geography,
participant
demographics.
The
risk
bias
was
assessed
using
Newcastle-Ottawa
Scales.
main
outcome
prevalence.
estimates
95%
confidence
intervals
determined
random
effects
Subgroup
analyses
undertaken
evaluate
such
as
design
geography.
Meta-regression
conducted
assess
associations
between
year.
Results
106
full-text
articles
identified.
estimated
54
reporting
all
medication
classes
37%
(95%
CI:
31-43%).
Differences
different
numerical
thresholds,
publication
Sex,
geographical
location
not
differences
Discussion
Our
highlights
common
particularly
older
adults
those
inpatient
settings.
Clinicians
should
be
aware
populations
who
have
an
increased
likelihood
experiencing
efforts
made
appropriateness
prescribed
medications
occurrence
potentially
Conclusions
implications
undertake
minimize
inappropriate
whenever
possible.